Activation of GABAA Receptors by Guanidinoacetate: A Novel Pathophysiological Mechanism

Guanidinoacetate methyltransferase (GAMT) deficiency is an autosomal recessively inherited disorder of creatine biosynthesis. The disease occurs in early life with developmental delay or arrest and several neurological symptoms, e.g., seizures and dyskinesia. Both the deficiency of high-energy phosphates in neurons and the neurotoxic action of the accumulated metabolite guanidinoacetate (GAA) are candidate mechanisms for the pathophysiology of this disease. To examine a potential role of GAA accumulation, we analyzed the electrophysiological responses of neurons induced by GAA application in primary culture and acute murine brain slices. GAA evoked picrotoxin- and bicuculline-sensitive GABA(A) receptor-mediated chloride currents with an EC(50) of 167 microM in cortical neurons. Pathophysiologically relevant GAA concentrations hyperpolarized globus pallidus neurons and reduced their spontaneous spike frequency with an EC(50) of 15.1 microM. Furthermore, GAA acted as a partial agonist at heterologously expressed GABA(A) but not GABA(B) receptors. The interaction of GAA with neuronal GABA(A) receptors represents a candidate mechanism explaining neurological dysfunction in GAMT deficiency.

[1]  R. Macdonald,et al.  Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture , 1991, Epilepsy Research.

[2]  D. Bertrand,et al.  Steroids inhibit nicotinic acetylcholine receptors. , 1991, Neuroreport.

[3]  M. Knopp,et al.  Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. , 1997, The Journal of pediatrics.

[4]  Hannah Monyer,et al.  Cerebellar GABAA receptor selective for a behavioural alcohol antagonist , 1990, Nature.

[5]  I. Stanford,et al.  Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro , 2000, The Journal of physiology.

[6]  Jens Frahm,et al.  Creatine replacement therapy in guanidineoacetate methyltransferase deficiency, a novel inborn error of metabolism , 1996, The Lancet.

[7]  S. Stöckler‐Ipsiroglu,et al.  Guanidinoacetate methyltransferase (GAMT) deficiency: non-invasive enzymatic diagnosis of a newly recognized inborn error of metabolism. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[8]  K. Staley,et al.  Modulation of mammalian dendritic GABAA receptor function by the kinetics of Cl− and HCO3− transport , 1999, The Journal of physiology.

[9]  E. Sigel,et al.  Functional characteristics and sites of gene expression of the alpha 1, beta 1, gamma 2-isoform of the rat GABAA receptor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  E. Mayatepek,et al.  Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. , 2001, Molecular genetics and metabolism.

[11]  P. D. De Deyn,et al.  Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. , 1997, Metabolism: clinical and experimental.

[12]  M. Tosetti,et al.  Brain creatine depletion: Guanidinoacetate methyltransferase deficiency (improving with creatine supplementation) , 2000, Neurology.

[13]  P. D. De Deyn,et al.  Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture , 1990, Annals of neurology.

[14]  R. D'Hooge,et al.  Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice , 1992, Journal of the Neurological Sciences.

[15]  R. D'Hooge,et al.  Uraemic guanidino compounds inhibit γ-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones , 1999, Neuroscience Letters.

[16]  K. Staley,et al.  Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors , 1995, Science.

[17]  Antoine Depaulis,et al.  Endogenous control of epilepsy: The nigral inhibitory system , 1994, Progress in Neurobiology.

[18]  F. Hanefeld,et al.  Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. , 1996, American journal of human genetics.

[19]  A. Connelly,et al.  Guanidinoacetate methyltransferase deficiency: new clinical features. , 1997, Pediatric neurology.

[20]  F. Marshall,et al.  Calcium sensing properties of the GABAB receptor , 1999, Neuropharmacology.

[21]  P. Seeburg,et al.  Modulation of GABAA Receptor tert‐[35S]Butylbicyclophosphorothionate Binding by Antagonists: Relationship to Patterns of Subunit Expression , 1996 .

[22]  G Helms,et al.  Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism , 1994, Pediatric Research.

[23]  P. D. De Deyn,et al.  Therapeutic trial of arginine restriction in creatine deficiency syndrome , 1998, European Journal of Pediatrics.

[24]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[25]  B. Liss,et al.  Alternative sulfonylurea receptor expression defines metabolic sensitivity of K‐ATP channels in dopaminergic midbrain neurons , 1999, The EMBO journal.

[26]  J. Roeper,et al.  Activity‐dependent formation of perforated synapses in cultured hippocampal neurons , 1999, The European journal of neuroscience.

[27]  J. Walker.  Creatine: biosynthesis, regulation, and function. , 2006, Advances in enzymology and related areas of molecular biology.